Selective Renal Dopamine-1 Receptor Stimulation in Man

References

• McDonald R H, Jr, Goldberg L I, McNay J L, Tuttle E P, Jr. Effects of dopamine in man; augmentation of sodium excretion, glomerular filtration rate and renal plasma flow. J Clin Invest 1964; 43: 1116–1124
   PubMed Web of Science ®Google Scholar
• Alexander R W, Jr, Gill J R, Yamabe H, Lovenberg W, Keiser H R. Effects of dietary sodium and of acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man. J Clin Invest 1974; 54: 194–200
   PubMed Web of Science ®Google Scholar
• Ball S G, Oats N S, Lee M R. Urinary dopamine in man and rat: effects of inorganic salts on dopamine excretion. Clin Sci Mol Med 1978; 55: 167–173
   PubMedGoogle Scholar
• Carey R M, Van Loon G R, Baines A D, Ortt E. Decreased plasma and urinary dopamine during dietary sodium depletion in man. J Clin Endo Metab 1981; 52: 903–909
   PubMed Web of Science ®Google Scholar
• Faucheux B, Buu N T, Kuchel O. Effects of saline and albumin on plasma and urinary catecholamines in dogs. Am J Physiol 1977; 232: F123–F127
   PubMed Web of Science ®Google Scholar
• Goldberg L I. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev 1972; 24: 1–29
   PubMed Web of Science ®Google Scholar
• Goldberg L I, Weder A B. Connections between endogenous dopamine, dopamine receptors and sodium excretion: evidences and hypotheses. Rec Adv Clin Pharmacol, P Turner, D. Shand. McMillan, New York 1980; 149–166
   Google Scholar
• Lee M R. Dopamine and the kidney. Clin Sci 1982; 62: 439–448
   PubMed Web of Science ®Google Scholar
• Felder R A, Belcher M, Eisner G M, Jose P A. Cortical tubular and glomerular dopamine receptors in the rat kidney. Am J Physiol 1984; 246: F557–F568
   PubMed Web of Science ®Google Scholar
• Felder R A, Belcher M, Calcagno P L, Jose P A. Dopamine receptors in the proximal tubule of the rabbit. Am J Physiol 1984; 247: F499–F505
   PubMed Web of Science ®Google Scholar
• Shultz P, Sedor J, Abboud H. Dopamine type 1 receptor associated with cyclic AMP accumulation in cultured rat mesangial cells. Kidney Int 1986; 29: 345a, (abstr)
   Web of Science ®Google Scholar
• Goldberg L I, Glock D, Kohli J D, Barnett A. Separation of peripheral dopamine receptors by a selective DA1 agonist, SCH 23390. Hypertension 1984; 6(Suppl. I)I25–I30
   PubMed Web of Science ®Google Scholar
• Frederickson E D, Bradley T, Goldberg L I. Blockade of renal effects of dopamine in the dog with the DA1 antagonist Sch 23390. Am J Physiol 1985; 249: F236–F240
   PubMed Web of Science ®Google Scholar
• Weinstock J, Wilson J W, Ladd D L, Brush C K, Pfeiffer F R, Kuo G Y, Holden K C, Kim C F, Hahn R A, Wordell J R, Tibia A J, Setter P E, Sarau H M, Ridley P T. Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxyl-1-phenyl-1H-3 benzazepines. J Med Chem 1980; 23: 973–975
   PubMed Web of Science ®Google Scholar
• Ohlstein E H, Zabko-Potapovich B, Berkowitz B A. The DA1 receptor agonist fenoldopam (SKF 82526-J) is also an alpha 2 adrenoceptor antagonist. Eur J Pharmacol 1985; 118: 321–329
   PubMed Web of Science ®Google Scholar
• Stote R M, Dubb J W, Familiar R G, Erb B B, Alexander F. A new oral renal vasodilator, fenoldopam. Clin Pharm Ther. 1983; 34: 309–315
   PubMed Web of Science ®Google Scholar
• Carey R M, Stote R M, Dubb J W, Townsend L H, Rose C E, Kaiser D L. Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension. J Clin Invest 1984; 74: 2198–2207
   PubMed Web of Science ®Google Scholar
• Weinstock J, Wilson J W, Ladd D L, Brenner M, Ackerman D M, Blumberg A L, Hahn R A, Hieble J P, Sarau H M, Wiebelhaus V D. Dopamine benzazepines with divergent cardiovascular profiles. Am Chem Soc Symp Series 1983; 224L: 157–167
   Google Scholar
• Hahn R A, Wardell J R, Sarau H M, Ridley P T. Characterization of the peripheral and central effects of SKF 82526-J, a novel dopamine receptor agonist. J Pharmacol Exp Ther 1982; 223: 305–313
   PubMed Web of Science ®Google Scholar
• Ackerman D M, Blumberg A L, McCafferty J P, Sherman S S, Weinstock J, Kaiser C, Berkowitz B. Potential usefulness of renal vasodilators in hypertension and renal disease: SKF 82526. Fed Proc 1983; 42: 186–190
   PubMedGoogle Scholar
• Ohlstein E H, Zabko-Potapovich B, Berkowitz B A. Studies on vascular dopamine receptors with the dopamine receptor agonist: SKF 82526. J Pharmacol Exp Ther 1984; 229: 433–439
   PubMed Web of Science ®Google Scholar
• Berkowitz B A, Ohlstein E H. Cardiovascular dopamine receptors: recent advances in agonist and antagonists of the DA-1 receptor. J Cardiovasc Pharmacol 1984; 6(Suppl 4)S559–S563
   PubMed Web of Science ®Google Scholar
• DeWardsen H E. The control of sodium excretion. Handbook of Physiology: Renal Physiology, J Orloff, R W Berliner, S R Geiger. Willilams and Wilkins, Co., Baltimore, MD 1973; 677–720
   Google Scholar
• Rose N B. Clinical Physiology of Acid-base and Electrolyte Disorders. McGraw-Hill Book Co., New York 1977; 1–548
   Google Scholar
• Kimura T, Abe K, Ota K, Omata K, Shoji M, Kudo K, Matsui K, Inoue M, Yasujima M, Yoshinaga K. Effects of acute water load hypertonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans. J Clin Endocrinol Metab 1986; 62: 1003–1010
   PubMed Web of Science ®Google Scholar
• Laragh J H. Atrial natriuretic hormone, the renin-aldosterone axis and blood pressure-electrolyte homeostasis. N Engl J Med 1985; 313: 1330–1340
   PubMed Web of Science ®Google Scholar
• Hardaker W T, Wechsler A S. Redistribution of renal intracortical blood flow during dopamine infusion in dogs. Circ Res 1973; 33: 437–444
   PubMed Web of Science ®Google Scholar
• Knox G K, Mertz J I, Burnett J C, Jr, Haramati A. Role of hydrostatic and oncotic pressures in renal sodium reabsorption. Circ Res 1983; 52: 491–500
   PubMed Web of Science ®Google Scholar